Published in Am J Cardiovasc Drugs on January 01, 2009
Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res (2011) 1.26
PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal. Nature (2015) 0.97
Adenosine monophosphate-activated protein kinase in diabetic nephropathy. Kidney Res Clin Pract (2016) 0.78
A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy. Clin Pharmacol (2010) 0.76
Benzophenone and its analogs bind to human glyoxalase 1. Bioorg Med Chem Lett (2015) 0.75
Febuxostat. Drugs (2008) 2.78
Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs (2009) 1.56
Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs (2011) 1.47
Olmesartan medoxomil: in children and adolescents with hypertension. Drugs (2010) 1.44
Albumin-bound Paclitaxel: in metastatic breast cancer. Drugs (2006) 1.42
Gadofosveset. Drugs (2006) 1.42
Sumatriptan fast-disintegrating/rapid-release tablets. Drugs (2006) 1.39
Delapril/manidipine. Drugs (2006) 1.38
Blonanserin: a review of its use in the management of schizophrenia. CNS Drugs (2010) 1.30
Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatr Drugs (2009) 1.27
Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma. Drugs (2011) 1.25
Pioglitazone: a review of its use in type 2 diabetes mellitus. Drugs (2006) 1.23
Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence. Drugs (2009) 1.22
Ropivacaine: a review of its use in regional anaesthesia and acute pain management. Drugs (2005) 1.19
Zolpidem: a review of its use in the management of insomnia. CNS Drugs (2005) 1.18
Trastuzumab: A review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer. Drugs (2010) 1.17
Daptomycin. Drugs (2004) 1.12
Insulin glargine: an updated review of its use in the management of diabetes mellitus. Drugs (2003) 1.11
Memantine: a review of its use in Alzheimer's disease. Drugs (2006) 1.10
Paroxetine controlled release. CNS Drugs (2004) 1.10
Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults. Drugs Aging (2010) 1.08
Imiquimod: in superficial basal cell carcinoma. Am J Clin Dermatol (2005) 1.08
Afatinib: first global approval. Drugs (2013) 1.07
Deferasirox : a review of its use in the management of transfusional chronic iron overload. Drugs (2007) 1.02
Dalfampridine extended release: in multiple sclerosis. CNS Drugs (2010) 1.02
Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma. Drugs (2002) 0.99
Sorafenib: in hepatocellular carcinoma. Drugs (2008) 0.98
Levobupivacaine: a review of its use in regional anaesthesia and pain management. Drugs (2010) 0.97
Remifentanil : a review of its analgesic and sedative use in the intensive care unit. Drugs (2006) 0.97
Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia. Drugs (2009) 0.97
Fenofibrate: a review of its use in dyslipidaemia. Drugs (2011) 0.97
Oxycodone/Naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation. Drugs (2014) 0.97
Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults. Drugs (2008) 0.96
Lutropin alfa. Drugs (2008) 0.96
Pirfenidone: a review of its use in idiopathic pulmonary fibrosis. Drugs (2015) 0.96
Basiliximab: a review of its use as induction therapy in renal transplantation. Drugs (2003) 0.96
Pegaptanib: in exudative age-related macular degeneration. Drugs (2005) 0.96
Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection. Drugs (2009) 0.94
Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis. Drugs (2010) 0.94
Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV). Paediatr Drugs (2009) 0.94
Moxonidine: a review of its use in essential hypertension. Drugs (2006) 0.93
Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis. Drugs (2002) 0.93
Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder. Drugs (2002) 0.92
Maraviroc. Drugs (2007) 0.92
Octreotide long-acting release (LAR): a review of its use in the management of acromegaly. Drugs (2010) 0.92
Rasagiline: a review of its use in the management of Parkinson's disease. Drugs (2007) 0.91
Cevimeline. Drugs (2008) 0.91
Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients. Paediatr Drugs (2009) 0.90
Tacrolimus: in heart transplant recipients. Drugs (2006) 0.90
Raloxifene: a review of its use in the prevention of invasive breast cancer. Drugs (2008) 0.89
Budesonide/formoterol: a review of its use in asthma. Drugs (2004) 0.88
Darifenacin: in the treatment of overactive bladder. Drugs Aging (2004) 0.88
Etoricoxib. Drugs (2002) 0.88
Extended-release intramuscular naltrexone (VIVITROL®): a review of its use in the prevention of relapse to opioid dependence in detoxified patients. CNS Drugs (2013) 0.88
Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention. Drugs (2005) 0.88
Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler. Drugs (2006) 0.87
Celecoxib: a review of its use in the management of arthritis and acute pain. Drugs (2007) 0.87
Prolonged-release nicotinic acid: a review of its use in the treatment of dyslipidaemia. Drugs (2005) 0.87
Ranibizumab. Drugs (2007) 0.87
Quetiapine: a review of its use in the management of bipolar depression. CNS Drugs (2012) 0.87
Methylphenidate controlled-delivery capsules (EquasymXL, Metadate CD): a review of its use in the treatment of children and adolescents with attention-deficit hyperactivity disorder. Paediatr Drugs (2006) 0.86
Pegylated liposomal doxorubicin: a guide to its use in various malignancies. BioDrugs (2013) 0.86
Colesevelam: a review of its use in hypercholesterolemia. Am J Cardiovasc Drugs (2007) 0.86
Adalimumab: a review of its use in rheumatoid arthritis. BioDrugs (2004) 0.85
Sodium oxybate: a review of its use in the management of narcolepsy. CNS Drugs (2007) 0.85
Bisoprolol: a review of its use in chronic heart failure. Drugs (2002) 0.85
Paliperidone extended release: a review of its use in the management of schizophrenia. Drugs (2010) 0.84
Abiraterone acetate: in metastatic castration-resistant prostate cancer. Drugs (2011) 0.84
Mannitol dry powder for inhalation: in patients with cystic fibrosis. Drugs (2012) 0.84
Bevacizumab: in first-line treatment of advanced and/or metastatic renal cell carcinoma. BioDrugs (2008) 0.84
Enfuvirtide: a review of its use in the management of HIV infection. Drugs (2005) 0.84
Sapropterin: a review of its use in the treatment of primary hyperphenylalaninaemia. Drugs (2009) 0.83
Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease. Drugs (2012) 0.83
Clevidipine: a review of its use in the management of acute hypertension. Am J Cardiovasc Drugs (2009) 0.83
Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD. Treat Respir Med (2004) 0.83
Aripiprazole: in adolescents with schizophrenia. Paediatr Drugs (2007) 0.83
Enteric-coated mycophenolate sodium: a review of its use in the prevention of renal transplant rejection. Drugs (2008) 0.83
Everolimus: in advanced renal cell carcinoma. Drugs (2009) 0.82
Inhaled salmeterol/fluticasone propionate: a review of its use in chronic obstructive pulmonary disease. Drugs (2004) 0.82
Spotlight on atomoxetine in attention-deficit hyperactivity disorder in children and adolescents. CNS Drugs (2010) 0.82
Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications. Drugs (2006) 0.82
Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease. CNS Drugs (2007) 0.82
Extended-release carbamazepine capsules : in bipolar I disorder. CNS Drugs (2005) 0.82
Valsartan: a review of its use in patients with heart failure and/or left ventricular systolic dysfunction after myocardial infarction. Am J Cardiovasc Drugs (2004) 0.82
Prasugrel: a review of its use in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Drugs (2009) 0.81
Fentanyl transdermal matrix patch (Durotep MT patch; Durogesic DTrans; Durogesic SMAT): in adults with cancer-related pain. Drugs (2008) 0.81
Lixisenatide: first global approval. Drugs (2013) 0.81
Albiglutide: a review of its use in patients with type 2 diabetes mellitus. Drugs (2015) 0.81
Lisdexamfetamine. Paediatr Drugs (2007) 0.81
Adalimumab: a review of its use in the treatment of patients with ulcerative colitis. BioDrugs (2013) 0.80
Valdecoxib: a review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain. Drugs (2004) 0.80
Dalbavancin. Drugs (2008) 0.80
Entecavir: a review of its use in chronic hepatitis B. Drugs (2009) 0.80
Insulin lispro: a review of its use in the management of diabetes mellitus. Drugs (2007) 0.80
OROS hydromorphone prolonged release: a review of its use in the management of chronic, moderate to severe pain. CNS Drugs (2010) 0.80
Tigecycline: in community-acquired pneumonia. Drugs (2008) 0.80
Histamine dihydrochloride: in the management of acute myeloid leukaemia. Drugs (2011) 0.80
Bosentan: in pediatric patients with pulmonary arterial hypertension. Paediatr Drugs (2010) 0.80
Budesonide/formoterol: in chronic obstructive pulmonary disease. Drugs (2004) 0.79